Suchergebnisse - "Köser, Claudio U"

PubPharm (85)

1

The exceptions that prove the rule-a historical view of bedaquiline susceptibility

enthalten in: Genome medicine | 2024

von Miotto, P. | Cirillo, D. | Schön, T. | +1

2

The exceptions that prove the rule—a historical view of bedaquiline susceptibility

enthalten in: Genome medicine | 2024

von Miotto, P. | Cirillo, D. | Schön, T. | +1

3

Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid

enthalten in: Microbiology spectrum | 2024

von Rupasinghe, P. | Reenaers, R. | Vereecken, J. | +9

4

Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Pandey, S. | Vilchèze, C. | Werngren, J. | +11

5

In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex

enthalten in: Microbiology spectrum | 2023

von Economou Lundeberg, E. | Andersson, V. | Wijkander, M. | +9

6

Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex

enthalten in: The European respiratory journal | 2023

von Köser, C. | Maurer, F.

CommentOn: Eur Respir J. 2022 Oct 13;60(4):. - PMID 35301246

7

Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region : Action is Needed by all Member States

enthalten in: The Journal of molecular diagnostics : JMD | 2022

von Maurer, F. | Shubladze, N. | Kalmambetova, G. | +23

8

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Bateson, A. | Ortiz Canseco, J. | McHugh, T. | +24

9

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance : A genotypic analysis

enthalten in: The Lancet. Microbe | 2022

von Walker, T. | Miotto, P. | Köser, C. | +123

CommentIn: Lancet Microbe. 2022 Sep;3(9):e645. - PMID 35659881

10

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents : implications for diagnosis and treatment

enthalten in: The European respiratory journal | April 14, 2022

von Georghiou, S. | Rodwell, T. | Korobitsyn, A. | +124

1
2
3
4
5
6
7
8
9
Nächster »
[9]